Jacobs Levy Equity Management, Inc Dynavax Technologies Corp Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q3 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 118,484 shares of DVAX stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
118,484
Previous 116,874
1.38%
Holding current value
$1.31 Million
Previous $1.16 Million
1.47%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DVAX
# of Institutions
303Shares Held
120MCall Options Held
293KPut Options Held
311K-
Black Rock Inc. New York, NY21.9MShares$242 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.7MShares$174 Million4.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$89.6 Million0.0% of portfolio
-
State Street Corp Boston, MA6.29MShares$69.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.53MShares$50.1 Million0.02% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.4B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...